Features of the 1st trimester of pregnancy course with severe deficiency of 25(OH)D
The course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network contributes to the development of an imbalance in the work of the whole organism, which ensures the growth and development of the embryo from the first day...
Saved in:
Published in | Gynecological endocrinology Vol. 37; no. S1; pp. 49 - 53 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
20.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network contributes to the development of an imbalance in the work of the whole organism, which ensures the growth and development of the embryo from the first days of gestation. It has been demonstrated that vitamin D can act as an immune regulator during implantation, providing a protective effect in the entire period of pregnancy.
The aim of this study is to assess the features of the course of pregnancy in patients with different levels of vitamin D in the blood in the first trimester.
A prospective multicenter randomized study was conducted in the North-West region of the Russian Federation among 88 pregnant women in the first trimester of gestation (up to 13 weeks). All patients were divided into 3 groups depending on the initial level of vitamin D (group 1-14 women with a 25(OH)D < 10 ng/ml, group 2-62 pregnant women from 10 to 30 ng/ml, group 3-12 pregnant women with a vitamin D content >30 ng/ml).
Criteria of inclusion: pregnant women from 20 to 44 years of the first trimester of gestation (up to 13 weeks) with the studied level of vitamin D in the blood serum; singleton pregnancy; BMI ≤30 kg/m2; signing by the patient of informed consent for inclusion in the study group.
In group 1, 86% of patients with severe vitamin D deficiency were diagnosed with threatened miscarriage, which is significantly higher than in group 3 (85.7% and 33.3%, χ
2
= 7.490, p = .007). At the same time, retrochorial hematoma in group 1 occurred 3.5 times more often than in group 3 (57.1% and 16.67%, respectively, χ
2
= 4.473, p = .035). Subsequently, every 4
th
woman from the group with vitamin D deficiency gave birth earlier than expected, which was not observed among patients from group 3 (25%, 0%, χ
2
= 1.231, p = .268).
Prescribing cholecalciferol vitamin replacement therapy as part of complex preserving therapy for threatening miscarriage, followed by monitoring its blood level and deviating from normal parameters, contributing to a favorable course of pregnancy and improving perinatal outcomes. |
---|---|
AbstractList | The course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network contributes to the development of an imbalance in the work of the whole organism, which ensures the growth and development of the embryo from the first days of gestation. It has been demonstrated that vitamin D can act as an immune regulator during implantation, providing a protective effect in the entire period of pregnancy.
The aim of this study is to assess the features of the course of pregnancy in patients with different levels of vitamin D in the blood in the first trimester.
A prospective multicenter randomized study was conducted in the North-West region of the Russian Federation among 88 pregnant women in the first trimester of gestation (up to 13 weeks). All patients were divided into 3 groups depending on the initial level of vitamin D (group 1-14 women with a 25(OH)
< 10 ng/ml, group 2-62 pregnant women from 10 to 30 ng/ml, group 3-12 pregnant women with a vitamin D content >30 ng/ml).
Criteria of inclusion: pregnant women from 20 to 44 years of the first trimester of gestation (up to 13 weeks) with the studied level of vitamin D in the blood serum; singleton pregnancy; BMI ≤30 kg/m2; signing by the patient of informed consent for inclusion in the study group.
In group 1, 86% of patients with severe vitamin D deficiency were diagnosed with threatened miscarriage, which is significantly higher than in group 3 (85.7% and 33.3%,
= 7.490,
= .007). At the same time, retrochorial hematoma in group 1 occurred 3.5 times more often than in group 3 (57.1% and 16.67%, respectively,
= 4.473,
= .035). Subsequently, every 4
woman from the group with vitamin D deficiency gave birth earlier than expected, which was not observed among patients from group 3 (25%, 0%,
= 1.231,
= .268).
Prescribing cholecalciferol vitamin replacement therapy as part of complex preserving therapy for threatening miscarriage, followed by monitoring its blood level and deviating from normal parameters, contributing to a favorable course of pregnancy and improving perinatal outcomes. INTRODUCTIONThe course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network contributes to the development of an imbalance in the work of the whole organism, which ensures the growth and development of the embryo from the first days of gestation. It has been demonstrated that vitamin D can act as an immune regulator during implantation, providing a protective effect in the entire period of pregnancy. OBJECTIVEThe aim of this study is to assess the features of the course of pregnancy in patients with different levels of vitamin D in the blood in the first trimester. MATERIALS AND METHODSA prospective multicenter randomized study was conducted in the North-West region of the Russian Federation among 88 pregnant women in the first trimester of gestation (up to 13 weeks). All patients were divided into 3 groups depending on the initial level of vitamin D (group 1-14 women with a 25(OH)D < 10 ng/ml, group 2-62 pregnant women from 10 to 30 ng/ml, group 3-12 pregnant women with a vitamin D content >30 ng/ml). INTERVENTIONSCriteria of inclusion: pregnant women from 20 to 44 years of the first trimester of gestation (up to 13 weeks) with the studied level of vitamin D in the blood serum; singleton pregnancy; BMI ≤30 kg/m2; signing by the patient of informed consent for inclusion in the study group. MAIN OUTCOME MEASURES AND RESULTSIn group 1, 86% of patients with severe vitamin D deficiency were diagnosed with threatened miscarriage, which is significantly higher than in group 3 (85.7% and 33.3%, χ2 = 7.490, p = .007). At the same time, retrochorial hematoma in group 1 occurred 3.5 times more often than in group 3 (57.1% and 16.67%, respectively, χ2 = 4.473, p = .035). Subsequently, every 4th woman from the group with vitamin D deficiency gave birth earlier than expected, which was not observed among patients from group 3 (25%, 0%, χ2 = 1.231, p = .268). CONCLUSIONPrescribing cholecalciferol vitamin replacement therapy as part of complex preserving therapy for threatening miscarriage, followed by monitoring its blood level and deviating from normal parameters, contributing to a favorable course of pregnancy and improving perinatal outcomes. The course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network contributes to the development of an imbalance in the work of the whole organism, which ensures the growth and development of the embryo from the first days of gestation. It has been demonstrated that vitamin D can act as an immune regulator during implantation, providing a protective effect in the entire period of pregnancy. The aim of this study is to assess the features of the course of pregnancy in patients with different levels of vitamin D in the blood in the first trimester. A prospective multicenter randomized study was conducted in the North-West region of the Russian Federation among 88 pregnant women in the first trimester of gestation (up to 13 weeks). All patients were divided into 3 groups depending on the initial level of vitamin D (group 1-14 women with a 25(OH)D < 10 ng/ml, group 2-62 pregnant women from 10 to 30 ng/ml, group 3-12 pregnant women with a vitamin D content >30 ng/ml). Criteria of inclusion: pregnant women from 20 to 44 years of the first trimester of gestation (up to 13 weeks) with the studied level of vitamin D in the blood serum; singleton pregnancy; BMI ≤30 kg/m2; signing by the patient of informed consent for inclusion in the study group. In group 1, 86% of patients with severe vitamin D deficiency were diagnosed with threatened miscarriage, which is significantly higher than in group 3 (85.7% and 33.3%, χ 2 = 7.490, p = .007). At the same time, retrochorial hematoma in group 1 occurred 3.5 times more often than in group 3 (57.1% and 16.67%, respectively, χ 2 = 4.473, p = .035). Subsequently, every 4 th woman from the group with vitamin D deficiency gave birth earlier than expected, which was not observed among patients from group 3 (25%, 0%, χ 2 = 1.231, p = .268). Prescribing cholecalciferol vitamin replacement therapy as part of complex preserving therapy for threatening miscarriage, followed by monitoring its blood level and deviating from normal parameters, contributing to a favorable course of pregnancy and improving perinatal outcomes. |
Author | Kovaleva, I. Bespalova, O. Bakleicheva, M. |
Author_xml | – sequence: 1 givenname: M. orcidid: 0000-0002-0103-8583 surname: Bakleicheva fullname: Bakleicheva, M. organization: "The Research Institute of Obstetrics, Gynecology and Reproductology Named After D.O.Ott" – sequence: 2 givenname: O. orcidid: 0000-0002-6542-5953 surname: Bespalova fullname: Bespalova, O. organization: "The Research Institute of Obstetrics, Gynecology and Reproductology Named After D.O.Ott" – sequence: 3 givenname: I. surname: Kovaleva fullname: Kovaleva, I. organization: OOO "AVA-PETER" |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34937507$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMtOwzAQRS0EoqXwCaAsYRHwM453IN5SpS6AteU4YwhK42InoP49jtqyZOOR7HM9M-cI7Xe-A4ROCb4kuMRXWAnChMKXFFOSDlwIKvfQlHDJciyLYh9NRyYfoQk6ivETY8K4pIdowrhiUmA5RS8PYPohQMy8y_oPyEjssz40S4g9hPFyFeC9M51dZ9YPIUL20_QfWYRvCJDV4BrbwPiaUCrOF08Xd8fowJk2wsm2ztDbw_3r7VM-Xzw-397Mc8sJ63PgpTN1bYhlHCQHUxfScsmLiilZgqoEVaVRMm3BWa1qJoyglRMp5ahglM3Q-ebfVfBfQxpYL5tooW1NB36ImhaE0VKVqcyQ2KA2-BgDOL1KO5qw1gTr0afe-dSjT731mXJn2xZDtYT6L7UTmIDrDdB0zoel-fGhrXVv1q0PLiRtTdTs_x6_TE-E4A |
CitedBy_id | crossref_primary_10_1016_j_heliyon_2023_e16954 |
Cites_doi | 10.1016/j.placenta.2020.01.013 10.14341/osteo2016248-48 10.1530/REP-18-0509 10.5114/ceji.2018.80053 10.3389/fimmu.2019.02739 10.1038/s41372-019-0343-8 10.1111/aji.13022 10.3945/ajcn.115.120873 10.1016/j.clinbiochem.2018.03.012 10.1111/jmwh.13014 10.1016/j.autrev.2016.07.015 10.1016/j.metabol.2017.10.001 10.1159/000486083 10.1530/JOE-14-0642 10.2174/1568026616666160617072521 10.1530/JOE-17-0491 10.1016/S2213-8587(18)30153-0 10.1016/j.jsbmb.2020.105669 10.3390/nu10111656 10.3390/ijerph15102241 |
ContentType | Journal Article |
Copyright | 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the ILARM EK (LLC). 2021 |
Copyright_xml | – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the ILARM EK (LLC). 2021 |
DBID | 0YH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1080/09513590.2021.2006527 |
DatabaseName | Taylor & Francis Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-0766 |
EndPage | 53 |
ExternalDocumentID | 10_1080_09513590_2021_2006527 34937507 2006527 |
Genre | Original Articles Randomized Controlled Trial Journal Article |
GroupedDBID | --- 00X 03L 0BK 0R~ 0YH 29I 36B 4.4 53G 5GY AAJNR AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABLKL ABPTK ABUPF ACENM ACFUF ACGEJ ACGFO ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AEGXH AENEX AEOZL AEYQI AFKVX AFWLO AGDLA AGFJD AGRBW AHMBA AIAGR AIJEM AIRBT AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P HZ~ IPNFZ KRBQP KSSTO KWAYT KYCEM LGLTD LJTGL M4Z O9- P2P RIG RNANH RVRKI RWL SV3 TAE TFDNU TFL TFW TUS UEQFS V1S ~1N 3V. 5VS 7X7 88E 8AO 8FI 8FJ AALIY AAORF ABJNI ABLIJ ABUWG ABWCV ABXYU ABZEW ACKZS ADBBV ADFOM ADFZZ AEIIZ AFKRA AFLEI AGYJP AJVHN ALIPV ALYBC AWYRJ BENPR BPHCQ BRMBE BVXVI CAG CCPQU CGR COF CUY CVF CYYVM CZDIS DRXRE DWTOO ECM EIF EJD FYUFA GROUPED_DOAJ H13 HMCUK JENTW M1P M44 NPM NUSFT PQQKQ PROAC PSQYO QQXMO RRB S0X TBQAZ TDBHL TERGH TUROJ UKHRP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c413t-e48fadda1c34e74ead67c4746b3978e9b5298a9709543d9d35a52bf58faf25323 |
IEDL.DBID | 0YH |
ISSN | 0951-3590 |
IngestDate | Thu Aug 15 23:55:28 EDT 2024 Fri Aug 23 03:40:43 EDT 2024 Sat Sep 28 08:21:04 EDT 2024 Tue Jun 13 19:16:45 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S1 |
Keywords | vitamin D receptor Vitamin D trophoblast pregnancy threatening miscarriage |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c413t-e48fadda1c34e74ead67c4746b3978e9b5298a9709543d9d35a52bf58faf25323 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-News-3 content type line 23 |
ORCID | 0000-0002-0103-8583 0000-0002-6542-5953 |
OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/09513590.2021.2006527 |
PMID | 34937507 |
PQID | 2613289861 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmed_primary_34937507 crossref_primary_10_1080_09513590_2021_2006527 proquest_miscellaneous_2613289861 informaworld_taylorfrancis_310_1080_09513590_2021_2006527 |
PublicationCentury | 2000 |
PublicationDate | 2021-12-20 |
PublicationDateYYYYMMDD | 2021-12-20 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Gynecological endocrinology |
PublicationTitleAlternate | Gynecol Endocrinol |
PublicationYear | 2021 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | CIT0010 CIT0021 CIT0001 Bespalova ON (CIT0009) 2019; 11 CIT0022 Mumford SL (CIT0020) 2018; 6 Hou H (CIT0011) 2020; 92 Dominguez M (CIT0005) 2017; 17 Bakleicheva MO (CIT0006) 2018; 67 Cyprian F (CIT0014) 2019; 10 Tamblyn JA (CIT0012) 2019; 158 Maddaloni E (CIT0023) 2018; 50 CIT0003 Borght MV (CIT0013) 2018; 62 CIT0002 Serrano-Díaz NC (CIT0019) 2018; 38 CIT0016 CIT0004 CIT0007 CIT0018 CIT0017 CIT0008 Zazerskaya IE (CIT0015) 2016; 2 |
References_xml | – volume: 92 start-page: 1 year: 2020 ident: CIT0011 publication-title: Placenta doi: 10.1016/j.placenta.2020.01.013 contributor: fullname: Hou H – volume: 2 start-page: 48 year: 2016 ident: CIT0015 publication-title: Osteoporosis osteopathy doi: 10.14341/osteo2016248-48 contributor: fullname: Zazerskaya IE – volume: 67 start-page: 4 issue: 3 year: 2018 ident: CIT0006 publication-title: Zakuszenbolezn contributor: fullname: Bakleicheva MO – volume: 158 start-page: 211 issue: 2 year: 2019 ident: CIT0012 publication-title: Reproduction doi: 10.1530/REP-18-0509 contributor: fullname: Tamblyn JA – ident: CIT0008 doi: 10.5114/ceji.2018.80053 – volume: 10 start-page: 2731 year: 2019 ident: CIT0014 publication-title: Front Immunol doi: 10.3389/fimmu.2019.02739 contributor: fullname: Cyprian F – ident: CIT0022 doi: 10.1038/s41372-019-0343-8 – ident: CIT0003 doi: 10.1111/aji.13022 – volume: 11 start-page: 89 year: 2019 ident: CIT0009 publication-title: J. Obstetrics and Gynecology contributor: fullname: Bespalova ON – ident: CIT0016 doi: 10.3945/ajcn.115.120873 – volume: 62 start-page: 2 year: 2018 ident: CIT0013 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2018.03.012 contributor: fullname: Borght MV – volume: 38 start-page: 43 issue: 1 year: 2018 ident: CIT0019 publication-title: Biomedica contributor: fullname: Serrano-Díaz NC – ident: CIT0021 doi: 10.1111/jmwh.13014 – ident: CIT0010 doi: 10.1016/j.autrev.2016.07.015 – ident: CIT0017 doi: 10.1016/j.metabol.2017.10.001 – volume: 50 start-page: 161 year: 2018 ident: CIT0023 publication-title: Front Horm Res doi: 10.1159/000486083 contributor: fullname: Maddaloni E – ident: CIT0001 doi: 10.1530/JOE-14-0642 – volume: 17 start-page: 631 issue: 6 year: 2017 ident: CIT0005 publication-title: Curr Top Med Chem doi: 10.2174/1568026616666160617072521 contributor: fullname: Dominguez M – ident: CIT0004 doi: 10.1530/JOE-17-0491 – volume: 6 start-page: 725 issue: 9 year: 2018 ident: CIT0020 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(18)30153-0 contributor: fullname: Mumford SL – ident: CIT0002 doi: 10.1016/j.jsbmb.2020.105669 – ident: CIT0007 doi: 10.3390/nu10111656 – ident: CIT0018 doi: 10.3390/ijerph15102241 |
SSID | ssj0013472 |
Score | 2.3259165 |
Snippet | The course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network contributes to... INTRODUCTIONThe course of physiological pregnancy is provided by many complementary factors. Thus, a deficiency in one of the links of the metabolic network... |
SourceID | proquest crossref pubmed informaworld |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 49 |
SubjectTerms | Adult Female Humans Pregnancy Pregnancy Outcome Pregnancy Trimester, First - blood Prospective Studies threatening miscarriage trophoblast Vitamin D Vitamin D - analogs & derivatives Vitamin D - blood Vitamin D Deficiency - blood vitamin D receptor |
Title | Features of the 1st trimester of pregnancy course with severe deficiency of 25(OH)D |
URI | https://www.tandfonline.com/doi/abs/10.1080/09513590.2021.2006527 https://www.ncbi.nlm.nih.gov/pubmed/34937507 https://search.proquest.com/docview/2613289861 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaglRAL4k15VEZigCGQ-BEnY0upKqTCAJVgiuzEZmurJh3499zlAXSoGFgiJYqT6Gznvs---46Qq8CEwgYu80zgIk8InXnaYBYwHE2kwas7TE4eP4WjiXh8k000YV6HVSKHdpVQRPmvxsmtTd5ExN0hKuAy9oHdsZLihZKpTdJmAL0xqs9_H_1sJIiyflNZTR7bNEk86x6z4p5WxEvXQ9DSFQ13yU6NIWmv6vQ9smGn-2RrXO-SH5AXxHVL4NF05igAPBrkBS1Qxx9VEfDifGE_UGnjk6YzjOKguBxLwUnahaWZRVUJTMnEW5m8fh7dDA7JZPjwej_y6uIJXgp-qfCsiBz8u3SQcmGVgAETqlQoERpAIJGNjWRxpGMFVhA8izMutWTGSWjlmOSMH5HWdDa1J4Qq4BzaKd9xX4uUOa2z2FgWasOVCoOsQ24bmyXzSiMjCRrp0drICRo5qY3cIfFvyyZFuTjhqkoiCf-j7WXTDQnMBNze0FM7W-YJcEEO9DEKgw45rvrn-3O4ABgG0Pf0H28-I9t4irEszD8nrWKxtBeASArTLcdcl7R7_UF_-AXHC9Vx |
link.rule.ids | 315,786,790,27535,27957,27958,59498,59499 |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV25TsQwELU4JKBB3CynkSigCCQ-4qREHArHQsEiQWXZiU23i5Zswd8zkwN2ixUFTYokTqKxnXnPnnlDyHFkY-EiXwQ28kkghCkCYzELGI42MeDVPSYndx_j7EXcvcrXsVwYDKtEDu1roYjqX42TGxej25C4c4QFXKYh0DtWcbxYMjVL5iUqrcCYDt-y350EURVwqsrJY5s2i2faYyb804R66XQMWvmimxWy3IBIelH3-iqZcf01stBttsnXyTMCuxEQaTrwFBAejT5LWqKQP8oi4MmPoXtHqY0vmg8wjIPieiwFL-mGjhYOZSUwJxNvZfLkKTu92iAvN9e9yyxoqicEOTimMnAi8fDzMlHOhVMCRkyscqFEbAGCJC61kqWJSRVYQfAiLbg0klkvoZVnkjO-Seb6g77bJlQB6TBehZ6HRuTMG1Ok1rHYWK5UHBUdctbaTH_UIhk6arVHGyNrNLJujNwh6bhldVmtTvi6lIjmf7Q9artBw1TA_Q3Td4PRpwYyyIE_JnHUIVt1__x8DheAwwD77vzjzYdkMet1H_TD7eP9LlnCSxjYwsI9MlcOR24f4ElpD6rx9w3Ddtd1 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV25TsQwELU4JESDuFlOI1FAEUh8xHGJgNVyIwESVJad2HS7q91swd8zk4OjQBQ0KZI4icZ25j175g0hB4lLhU9CEbkkZJEQtoiswyxgOLrMglcPmJx8e5f2nsXVi2yjCcdNWCVy6FALRVT_apzcwyK0EXEniAq41DGwO1ZRvFQyNU1mpRYao7ri197XRoKo6jdV1eSxTZvE89tjfrinH-Klv0PQyhV1F8lCgyHpad3pS2TK95fJ3G2zS75CHhHXTYBH00GgAPBoMi5piTr-qIqAJ4cj_4ZKG-80H2AUB8XlWApO0o88LTyqSmBKJt7K5OF97-h8lTx3L57OelFTPCHKwS-VkRdZgH-XTXIuvBIwYFKVCyVSBwgk89pJpjOrFVhB8EIXXFrJXJDQKjDJGV8jM_1B328QqoBz2KDiwGMrchasLbTzLLWOK5UmRYcctzYzw1ojwySt9GhjZINGNo2RO0R_t6wpq8WJUFcSMfyPtvttNxiYCbi9Yft-MBkb4IIc6GOWJh2yXvfP5-dwATAMoO_mP968R-Yezrvm5vLueovM4xUMa2HxNpkpRxO_A-CkdLvV8PsAgyDWng |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Features+of+the+1st+trimester+of+pregnancy+course+with+severe+deficiency+of+25%28OH%29D&rft.jtitle=Gynecological+endocrinology&rft.au=Bakleicheva%2C+M.&rft.au=Bespalova%2C+O.&rft.au=Kovaleva%2C+I.&rft.date=2021-12-20&rft.pub=Taylor+%26+Francis&rft.issn=0951-3590&rft.eissn=1473-0766&rft.volume=37&rft.issue=S1&rft.spage=49&rft.epage=53&rft_id=info:doi/10.1080%2F09513590.2021.2006527&rft.externalDBID=0YH&rft.externalDocID=2006527 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-3590&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-3590&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-3590&client=summon |